kb glutathione side effects Injections: & Benefits FDA Advisory No.2023-1833 || Public

Patients who benefit most are those seeking additional immune support, such as individuals with autoimmune health concerns, those recovering from illness or surgery, frequent travelers, or busy professionals managing high stress levels

The study's lead author is Ying Lai, PhD, a former postdoctoral scholar in Brunger's lab and now an assistant professor at Sichuan University in Chengdu, China

The earliest expected approval is late 2027, following completion of the Phase 3 TRIUMPH program

Interestingly, the treatment demonstrated dose-dependent therapeutic effects, with moderate dosages proving more effective than high doses (1,000 mg/kg), possibly due to pharmacodynamic principles, where excessive concentrations saturate biological pathways and diminish therapeutic outcomes (Tyagi et al., 2025